Medicine
BEVACIZUMAB 400 CIPLA
Key ingredient(s)
Bevacizumab
Available forms & strengths
Request this medicine| Form | Strength | Pack | Route | Icon |
|---|---|---|---|---|
| CONCENTRATE FOR SOLUTION FOR INFUSION | 400,0 mg | — | Parenteral |
|
Notes: SAHPRA secureId: CfDJ8L67LitnFgdOq0Uv0zyh2brMX3Jsi0phiturrGOm_O7-959wr7qPUGZhKpOQTOqum9WLescYWGeUyDEskB62fk84_8G5Fz3oDTB7u666OLbGORKZCqXFvxaVWauId2SRAA | Reg: 57/30.1/0233 | AppNo: 570233 | RegDate: 2024/11/19 | Applicant: Cipla Medpro (Pty) Ltd | Status: Registered